Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Martti Nurmi"'
Autor:
Härkönen, Lan Yu, Mervi Toriseva, Syeda Afshan, Mario Cangiano, Vidal Fey, Andrew Erickson, Heikki Seikkula, Kalle Alanen, Pekka Taimen, Otto Ettala, Martti Nurmi, Peter J. Boström, Markku Kallajoki, Johanna Tuomela, Tuomas Mirtti, Inès J. Beumer, Matthias Nees, Pirkko
Publikováno v:
Cancers; Volume 14; Issue 2; Pages: 278
Fibroblast growth factor receptors (FGFRs) 1–4 are involved in prostate cancer (PCa) regulation, but the role of FGFR-like 1 (FGFRL1) in PCa is unclear. FGFRL1 expression was studied by qRT-PCR and immunohistochemistry of patient tissue microarrays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::a7e5da609156dfb203e94117257246ad
Autor:
Lan Yu, Mervi Toriseva, Syeda Afshan, Mario Cangiano, Vidal Fey, Andrew Erickson, Heikki Seikkula, Kalle Alanen, Pekka Taimen, Otto Ettala, Martti Nurmi, Peter J. Boström, Markku Kallajoki, Johanna Tuomela, Tuomas Mirtti, Inès J. Beumer, Matthias Nees, Pirkko Härkönen
Publikováno v:
Cancers
Cancers, Vol 14, Iss 278, p 278 (2022)
Cancers, Vol 14, Iss 278, p 278 (2022)
Simple Summary Prostate cancer (PCa) is one of the most frequently diagnosed malignancies in men. PCa is primarily regulated by androgens, but other mechanisms, such as fibroblast growth factor receptor (FGFR) signaling, are also involved. In some pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f298e53db9bf3d98b939f4bc26c31296
https://trepo.tuni.fi/handle/10024/144754
https://trepo.tuni.fi/handle/10024/144754
Autor:
Ian F. Tannock, Antonio Finelli, Alexandre R. Zlotta, Tuomas Mirtti, Michael Jewett, Matti Laato, Bas W.G. van Rhijn, Srikala S. Sridhar, Peter J. Boström, M. J. Moore, Neil Fleshner, Martti Nurmi
Publikováno v:
Bladder Cancer
Background: Benefits of adjuvant chemotherapy (AC) and extent of pelvic lymph node dissection (PLND) in radical cystectomy (RC) are debated. Results from randomized trials are still expected. Objective: To analyze the effects of AC and PLND in two ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e608a2c05e15c56f1fb92aec663b6ed3
https://doi.org/10.3233/blc-150032
https://doi.org/10.3233/blc-150032
Autor:
Kalle Alanen, Hans Lilja, Angel M. Cronin, Otto Kauko, Henna Kekki, Riina-Minna Väänänen, Siina Vidbäck, Maria Rissanen, Kim Pettersson, Leni Kauko, Martti Nurmi
Publikováno v:
Clinical Biochemistry; 46(7-8), pp 670-674 (2013)
Objectives: The benefits of PSA (prostate specific antigen)-testing in prostate cancer remain controversial with a consequential need for validation of additional biomarkers. We used highly standardized reverse-transcription (RT)-PCR assays to compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::969de427c89ab1ca8a1625b4038541d4
http://juuli.fi/Record/0036799113
http://juuli.fi/Record/0036799113
Autor:
Timo Lövgren, Kim Pettersson, Alice Ylikoski, Martti Nurmi, Matti Karp, Kerttu Irjala, Hans Lilja, Jussi Nurmi
Publikováno v:
Europe PubMed Central
Background: Detection or quantification of circulating cancer cells has been proposed as an aid in detection and monitoring of several solid tumors. We investigated the classification accuracy of prostate-specific antigen (PSA) and human glandular ka
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcf8ffc1aed2b53084d096a502f98fb4
https://ora.ox.ac.uk/objects/uuid:2d5be1ac-ba5b-4aac-bda2-26f0b7799483
https://ora.ox.ac.uk/objects/uuid:2d5be1ac-ba5b-4aac-bda2-26f0b7799483
Various blood constituents can interfere with immunoassays, usually by binding the Fc portion of antibodies. Our previously developed assays for intact free prostate-specific antigen (PSA), free human kallikrein 2 (hK2), and total hK2 frequently yiel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4641b7a2f2db0de8c15223d87ae78954
https://ora.ox.ac.uk/objects/uuid:681bfaf5-dd5d-45cd-ba82-ee36ba2c0c86
https://ora.ox.ac.uk/objects/uuid:681bfaf5-dd5d-45cd-ba82-ee36ba2c0c86
Autor:
Kim Pettersson, Martti Nurmi, Timo Piironen, Timo Lövgren, Olli J. Heinonen, Hans Lilja, Kerttu Irjala
Background: The purpose of this study was to validate the use of whole-blood samples in the determination of circulating forms of prostate-specific antigen (PSA).Methods: Blood samples of hospitalized prostate cancer and benign prostatic hyperplasia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65ef5a1b01e2de9e2551dd87849546f6
https://ora.ox.ac.uk/objects/uuid:659ac7d1-abee-478f-853a-30ce972ba333
https://ora.ox.ac.uk/objects/uuid:659ac7d1-abee-478f-853a-30ce972ba333
Autor:
Kalle Alanen, Ivan Jambor, Ronald Borra, Heikki Minn, Riitta Parkkola, Kirsti Dean, Hannu J. Aronen, Virva Lepomaki, Jukka Kemppainen, Martti Nurmi, Eveliina Arponen
Publikováno v:
European Journal of Radiology, 81(11), 2966-2972. ELSEVIER IRELAND LTD
Objectives: We aimed to study the ability of contrast enhanced MRI at 1.5 T and C-11-acetate PET/CT, both individually and using fused data, to detect localized prostate cancer.Methods: Thirty-six men with untreated prostate cancer and negative for m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d234f4499bb0bc8402fe599b87b2a6f2
https://doi.org/10.1016/j.ejrad.2011.12.043
https://doi.org/10.1016/j.ejrad.2011.12.043
Autor:
Neil Fleshner, Michael A.S. Jewett, Alexandre R. Zlotta, Cynthia Kuk, David Horovitz, Polat Turker, Girish S. Kulkarni, Peter J. Boström, Tuomas Mirtti, Antonio Finelli, Martti Nurmi
Publikováno v:
BJU International. 110:E486-E493
Study Type – Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Elderly patients have more years to compound comorbidities and it has previously been shown that comorbidity is an important predictor of o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::027a71802e73da99858b765f654ef233
https://doi.org/10.1111/j.1464-410x.2012.11180.x
https://doi.org/10.1111/j.1464-410x.2012.11180.x
Autor:
Jianwu Xie, Shyh-Han Tan, Zhiyong Liao, Kalle Alanen, Tuomas Mirtti, Martti Nurmi, Hallgeir Rui, Ayush Dagvadorj, Marja T. Nevalainen
Publikováno v:
The International Journal of Biochemistry & Cell Biology. 42:2037-2046
Transcription factor Stat5a/b is critical for prostate cancer cell survival and for prostate xenograft tumor growth. In addition, the Stat5a/b signaling pathway may contribute to progression of organ-confined prostate cancer to castration-resistant a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0df13878195a672432f7b887bfc78d72
https://doi.org/10.1016/j.biocel.2010.09.008
https://doi.org/10.1016/j.biocel.2010.09.008